Emerging Technology
Diagnostix Elects Ger Van Jeveren To Its Board Of Directors Ahead Of Ipo
By Business Wire
Share
NEW YORK--(BUSINESS WIRE)--Diagnostix, the leading European med tech company, specialized in Artificial Intelligence diagnostics and co-founded by Giuliano Senese and Dr. Peter Velthuis has elected Ger van Jeveren to its Board of Directors. Van Jeveren, a seasoned Dutch entrepreneur with extensive experience in healthcare, brings a wealth of expertise and knowledge to the Diagnostix team.
Van Jeveren's track record speaks for itself. With decades of experience in the healthcare industry, he has founded and led several successful healthcare companies in the Netherlands and beyond. He is widely regarded as a leader and innovator in the industry, and his expertise and guidance will be invaluable to Diagnostix as the company continues to grow and expand.
"We are thrilled to welcome Ger van Jeveren to our Board of Directors," said Senese. "His deep knowledge of the healthcare industry, combined with his experience as an entrepreneur, makes him the perfect fit for our team. We look forward to working with him to further our mission of using technology to improve people's lives."
Dr. Velthuis echoed Senese's sentiment, saying, "Ger van Jeveren's track record in healthcare is second to none. He brings a wealth of expertise and knowledge to our company, and we are confident that he will help us to continue to grow and achieve our goals."
Van Jeveren, for his part, expressed his excitement at the opportunity to work with Diagnostix. “Artificial Intelligence will be the gamechanger for diagnostic purposes in the health, med and tech environment. I am proud to participate with Diagnostix in this disruptive segment and looking forward to work with this excellent team.” said van Jeveren.
With van Jeveren on board, Diagnostix is well positioned to continue its rapid growth and expansion. The company's cutting-edge technology and commitment to innovation and technology have already made a significant impact in the field of medical technology, and with van Jeveren's guidance, the future looks bright for the company and its co-founders.
For more information, please visit Diagnostix's website at https://diagnostix.ai
ContactsHelen Wang
legal@diagnostix.ai
First published on Mon, Feb 27, 2023
Enjoyed what you've read so far? Great news - there's more to explore!
Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.
Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.
Dive into TechDogs' treasure trove today and Know Your World of technology!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. All information / content found on TechDogs' site may not necessarily be reviewed by individuals with the expertise to validate its completeness, accuracy and reliability.
Tags:
Related News on Emerging Technology
Are Self-Driving Cars Driving Their Own Problems?
Fri, Apr 14, 2023
By TD NewsDesk
Will Virgin Galactic Reach New Heights Or Crash?
Fri, Jun 2, 2023
By Business Wire
Oceaneering Reports Fourth Quarter 2022 Results
Fri, Feb 24, 2023
By Business Wire
Exro Announces C$30 Million Bought Deal Financing
Tue, May 16, 2023
By PR Newswire
Is LinkedIn's 1 Billion Club Your AI Career Oasis?
Fri, Nov 3, 2023
By TD NewsDesk
Join The Discussion